A serious vulnerability in the open-source AI agent OpenClaw made it possible for arbitrary websites to take complete control ...
United Therapeutics Corporation , a public benefit corporation, today announced that its long-term pivotal phase 3 ADVANCE OUTCOMES study met its primary endpoint, with ralinepag reducing the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results